Neurodegeneration in ataxia-telangiectasia: Multiple roles of ATM kinase in cellular homeostasis

Developmental Dynamics

Volumn 247, Issue 1, 2018, Pages 33-46

  Choy, Kay Rui ^a   Watters, Dianne J ^a  

^a GRIFFITH UNIVERSITY   (Australia)

Author keywords

autophagy; insulin signaling; mitochondria; peroxisomes; Reactive oxygen species; synaptic vesicles

Indexed keywords

ATM PROTEIN; INSULIN; REACTIVE OXYGEN METABOLITE;

AGING; ATAXIA TELANGIECTASIA; AUTOPHAGY; CELL ACTIVATION; CELL PROLIFERATION; CYTOPLASM; DEGENERATIVE DISEASE; DISEASE ACTIVITY; DNA DAMAGE RESPONSE; HOMEOSTASIS; HUMAN; HYPOXIA; INSULIN SIGNALING; MITOCHONDRION; MOLECULAR DYNAMICS; NERVE CELL; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PEROXISOME; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SYNAPSE VESICLE; ANIMAL; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; ATAXIA TELANGIECTASIA; ATAXIA TELANGIECTASIA MUTATED PROTEINS; HOMEOSTASIS; HUMANS; MITOCHONDRIA; NERVE DEGENERATION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 85038405741     PISSN: 10588388     EISSN: 10970177     Source Type: Journal    
DOI: 10.1002/dvdy.24522     Document Type: Review

References (166)

1. Abraham RT. 1996. Phosphatidylinositol 3-kinase related kinases. Curr Opin Immunol 8:412–418.
2. Abraham RT. 2001. Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev 15:2177–2196.
3. Alexander A, Cai SL, Kim J, Nanez A, Sahin M, MacLean KH, Inoki K, Guan KL, Shen J, Person MD, Kusewitt D, Mills GB, Kastan MB, Walker CL. 2010. ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS. Proc Natl Acad Sci U S A 107:4153–4158.
4. Allen DM, van Praag H, Ray J, Weaver Z, Winrow CJ, Carter TA, Braquet R, Harrington E, Ried T, Brown KD, Gage FH, Barlow C. 2001. Ataxia telangiectasia mutated is essential during adult neurogenesis. Genes Dev 15:554–566.
5. Ambrose M, Goldstine JV, Gatti RA. 2007. Intrinsic mitochondrial dysfunction in ATM-deficient lymphoblastoid cells. Hum Mol Genet 16:2154–2164.
6. Ambrose M, Gatti RA. 2013. Pathogenesis of ataxia-telangiectasia: the next generation of ATM functions. Blood 121:4036–4045.
7. Armata HL, Golebiowski D, Jung DY, Ko HJ, Kim JK, Sluss HK. 2010. Requirement of the ATM/p53 tumor suppressor pathway for glucose homeostasis. Mol Cell Biol 30:5787–5794.
8. Baker A, Hogg TL, Warriner SL. 2016. Peroxisome protein import: a complex journey. Biochem Soc Trans 44:783–789.
9. Bakkenist CJ, Kastan MB. 2003. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421:499–506.
10. Barlow C, Hirotsune S, Paylor R, Liyanage M, Eckhaus M, Collins F, Shiloh Y, Crawley JN, Ried T, Tagle D, Wynshaw-Boris A. 1996. Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell 86: 159–171.
11. Barlow C, Dennery PA, Shigenaga MK, Smith MA, Morrow JD, Roberts LJ, Wynshaw-Boris A, Levine RL. 1999. Loss of the ataxia-telangiectasia gene product causes oxidative damage in target organs. Proc Natl Acad Sci U S A 96: 9915–9919.
12. Barlow C, Ribaut-Barassin C, Zwingman TA, Pope AJ, Brown KD, Owens JW, Larson D, Harrington EA, Haeberle AM, Mariani J, Eckhaus M, Herrup K, Bailly Y, Wynshaw-Boris A. 2000. ATM is a cytoplasmic protein in mouse brain required to prevent lysosomal accumulation. Proc Natl Acad Sci U S A 97:871–876.
13. Barzilai A. 2013. The interrelations between malfunctioning DNA damage response (DDR) and the functionality of the neuro-glio-vascular unit. DNA Repair 12: 543–557.
14. Bencokova Z, Kaufmann MR, Pires IM, Lecane PS, Giaccia AJ, Hammond EM. 2009. ATM activation and signaling under hypoxic conditions. Mol Cell Biol 29:526–537.
15. Bhat AH, Dar KB, Anees S, Zargar MA, Masood A, Sofi MA, Ganie SA. 2015. Oxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insight. Biomed Pharmacother 74:101–110.
16. Bhatt N, Ghosh R, Roy S, Gao Y, Armanios M, Cheng L, Franco S. 2016. Robust reprogramming of Ataxia-Telangiectasia patient and carrier erythroid cells to induced pluripotent stem cells. Stem Cell Res 17:296–305.
17. Biagiotti S, Menotta M, Orazi S, Spapperi C, Brundu S, Fraternale A, Bianchi M, Rossi L, Chessa L, Magnani M. 2016. Dexamethasone improves redox state in ataxia telangiectasia cells by promoting an NRF2-mediated antioxidant response. FEBS J 283:3962–3978.
18. Biton S, Barzilai A, Shiloh Y. 2008. The neurological phenotype of ataxia-telangiectasia: solving a persistent puzzle. DNA Repair 7:1028–1038.
19. Boder E, Sedgwick RP. 1958. Ataxia-telangiectasia; a familial syndrome of progressive cerebellar ataxia, oculocutaneous telangiectasia and frequent pulmonary infection. Pediatrics 21:526–554.
20. Boehrs JK, He J, Halaby MJ, Yang DQ. 2007. Constitutive expression and cytoplasmic compartmentalization of ATM protein in differentiated human neuron-like SH-SY5Y cells. J Neurochem 100:337–345.
21. Borghesani PR, Alt FW, Bottaro A, Davidson L, Aksoy S, Rathbun GA, Roberts TM, Swat W, Segal RA, Gu Y. 2000. Abnormal development of Purkinje cells and lymphocytes in Atm mutant mice. Proc Natl Acad Sci U S A 97:3336–3341.
22. Cam H, Easton JB, High A, Houghton PJ. 2010. mTORC1 signaling under hypoxic conditions is controlled by ATM-dependent phosphorylation of HIF-1α. Mol Cell 40:509–520.
23. Campbell A, Krupp B, Bushman J, Noble M, Pröschel C, Mayer-Pröschel M. 2015. A novel mouse model for ataxia-telangiectasia with a N-terminal mutation displays a behavioural defect and a low incidence of lymphoma but no increased oxidative burden. Hum Mol Genet 24:6331–6349.
24. Campbell A, Bushman J, Munger J, Noble M, Pröschel C, Mayer-Pröschel M. 2016. Mutation of ataxia–telangiectasia mutated is associated with dysfunctional glutathione homeostasis in cerebellar astroglia. Glia 64:227–239.
25. Carlessi L, Poli EF, De Filippis L, Delia D. 2013. ATM-deficient human neural stem cells as an in vitro model system to study neurodegeneration. DNA Repair 12:605–611.
26. Carlessi L, Poli EF, Bechi G, Mantegazza M, Pascucci B, Narciso L, Dogliotti E, Sala C, Verpelli C, Lecis D, Delia D. 2014. Functional and molecular defects of hiPSC-derived neurons from patients with ATM deficiency. Cell Death Dis 5:e1342.
27. Chen H, Chan DC. 2009. Mitochondrial dynamics—fusion, fission, movement, and mitophagy—in neurodegenerative diseases. Hum Mol Genet 18:R169–76.
28. Chen J, Chen Y, Vail G, Chow H, Zhang Y, Louie L, Li J, Hart RP, Plummer MR, Herrup K. 2016. The impact of glutamine supplementation on the symptoms of ataxia-telangiectasia: a preclinical assessment. Mol Neurodegener 11:60.
29. Chen P, Peng C, Luff J, Spring K, Watters D, Bottle S, Furuya S, Lavin MF. 2003. Oxidative stress is responsible for deficient survival and dendritogenesis in purkinje neurons from ataxia-telangiectasia mutated mutant mice. J Neurosci 23:11453–1160.
30. Chiesa N, Barlow C, Wynshaw-Boris A, Strata P, Tempia F. 2000. Atm-deficient mice Purkinje cells show age-dependent defects in calcium spike bursts and calcium currents. Neurosci 96:575–583.
31. Cosentino C, Grieco D, Costanzo V. 2011. ATM activates the pentose phosphate pathway promoting anti-oxidant defence and DNA repair. EMBO J 30:546–555.
32. D'Souza A, Parish IA, Krause DS, Kaech SM, Shadel GS. 2013. Reducing mitochondrial ROS improves disease-related pathology in a mouse model of ataxia-telangiectasia. Mol Ther 21:42–48.
33. Daniel JA, Pellegrini M, Lee JH, Paull TT, Feigenbaum L, Nussenzweig A. 2008. Multiple autophosphorylation sites are dispensable for murine ATM activation in vivo. J Cell Biol 183:777–783.
34. Daniel JA, Pellegrini M, Lee BS, Guo Z, Filsuf D, Belkina NV, You Z, Paull TT, Sleckman BP, Feigenbaum, L, Nussenzweig A. 2012. Loss of ATM kinase activity leads to embryonic lethality in mice. J Cell Biol 198:295–304.
35. De Cicco M, Rahim MS, Dames SA. 2015. Regulation of the target of rapamycin and other phosphatidylinositol 3-kinase-related kinases by membrane targeting. Membranes 5:553–575
36. de la Monte SM 2014. Type 3 diabetes is sporadic Alzheimer's disease: Mini-review. Eur Neuropsychopharmacol 24:1954–1960.
37. De Moura MB, dos Santos LS, Van Houten B. 2010. Mitochondrial dysfunction in neurodegenerative diseases and cancer. Environ Mol Mutagen 51:391–405.
38. Dibble CC, Elis W, Menon S, Qin W, Klekota J, Asara JM, Finan PM, Kwiatkowski DJ, Murphy LO, Manning BD. 2012. TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1. Mol Cell 47:535–546
39. Di Nardo A, Wertz MH, Kwiatkowski E, Tsai PT, Leech JD, Greene-Colozzi E, Goto J, Dilsiz P, Talos DM, Clish CB, Kwiatkowski DJ, Sahin M. 2014. Neuronal Tsc1/2 complex controls autophagy through AMPK-dependent regulation of ULK1. Hum Mol Genet 23:3865–3874.
40. Eaton JS, Lin ZP, Sartorelli AC, Bonawitz ND, Shadel GS. 2007. Ataxia-telangiectasia mutated kinase regulates ribonucleotide reductase and mitochondrial homeostasis. J Clin Invest 117:2723–2734.
41. Eilam R, Peter Y, Elson A, Rotman G, Shiloh Y, Groner Y, Segal M. 1998. Selective loss of dopaminergic nigro-striatal neurons in brains of Atm-deficient mice. Proc Natl Acad Sci U S A 95:12653–12656.
42. Elson A, Wang Y, Daugherty CJ, Morton CC, Zhou F, Campos-Torres J, Leder, P. 1996. Pleiotropic defects in ataxia-telangiectasia protein-deficient mice. Proc Natl Acad Sci U S A 93:13084–13089.
43. Enriquez-Rios V, Dumitrache LC, Downing SM, Li Y, Brown EJ, Russell HR, McKinnon PJ. 2017. DNA-PKcs, ATM and ATR interplay maintains genome integrity during neurogenesis. J Neurosci 37:893–905.
44. Fang EF, Scheibye-Knudsen M, Brace LE, Kassahun H, SenGupta T, Nilsen H, Mitchell JR, Croteau DL, Bohr VA. 2014. Defective mitophagy in XPA via PARP-1 hyperactivation and NAD+/SIRT1 reduction. Cell 157:882–896.
45. Fang EF, Kassahun H, Croteau DL, Scheibye-Knudsen M, Marosi K, Lu H, Shamanna RA, Kalyanasundaram S, Bollineni RC, Wilson MA, Iser WB, Wollman BN, Morevati M, Li J, Kerr JS, Lu Q, Waltz TB, Tian J, Sinclair DA, Mattson MP, Nilsen H, Bohr VA. 2016. NAD + Replenishment Improves Lifespan and Healthspan in Ataxia Telangiectasia Models via Mitophagy and DNA Repair. Cell Metab 24:566–581.
46. Federico A, Cardaioli E, Da Pozzo P, Formichi P, Gallus GN, Radi E. 2012. Mitochondria, oxidative stress and neurodegeneration. J Neurol Sci 322:254–262.
47. Gatti RA, Vinters HV. 1985. Cerebellar pathology in ataxia-telangiectasia: the significance of basket cells. Kroc Found Ser 19:225–232.
48. Gatti RA, Berkel I, Boder E, Braedt G, Charmley P, Concannon P, Ersoy F, Foroud T, Jaspers NG, Lange K, Lathrop GM, Leppert M, Nakamura Y, O'Connell P, Paterson M, Salser W, Sanal O, Silver J, Sparkes RS, Susi E, Weeks DE, Wei S, White R, Yoder F. 1988. Localization of an ataxia-telangiectasia gene to chromosome 11q22-23. Nature 336:577–580.
49. Gueven N, Luff J, Peng C, Hosokawa K, Bottle SE, Lavin MF. 2006. Dramatic extension of tumor latency and correction of neurobehavioral phenotype in Atm-mutant mice with a nitroxide antioxidant. Free Radic Biol Med 41:992–1000.
50. Guleria A, Chandna S. 2016. ATM kinase: much more than a DNA damage responsive protein. DNA Repair 39:1–20.
51. Guo Z, Kozlov S, Lavin MF, Person MD, Paull TT. 2010a. ATM activation by oxidative stress. Science 330:517–521.
52. Guo Z, Deshpande R, Paull TT. 2010b. ATM activation in the presence of oxidative stress. Cell Cycle 9:4805–4811.
53. Halaby MJ, Hibma JC, He J, Yang DQ. 2008. ATM protein kinase mediates full activation of Akt and regulates glucose transporter 4 translocation by insulin in muscle cells. Cell Signal 20:1555–1563.
54. Herzog KH, Chong MJ, Kapsetaki M, Morgan JI, McKinnon PJ. 1998. Requirement for Atm in ionizing radiation-induced cell death in the developing central nervous system. Science 280:1089–1091.
55. Hoche F, Seidel K, Theis M, Vlaho S, Schubert R, Zielen S, Kieslich M. 2012. Neurodegeneration in ataxia telangiectasia: what is new? What is evident? Neuropediatrics 43:119–129.
56. Hoche F, Frankenberg E, Rambow J, Theis M, Harding JA, Qirshi M, Seidel K, Barbosa-Sicard E, Porto L, Schmahmann JD, Kieslich M. 2014. Cognitive phenotype in ataxia-telangiectasia. Pediatr Neurol 51:297–310.
57. Huang J, Manning D. 2009. A complex interplay between Akt, TSC2 and the two mTOR complexes. Biochem Soc Trans 37: 217–222.
58. Jiang D, Zhang Y, Hart RP, Chen J, Herrup K, Li J. 2015. Alteration in 5-hydroxymethylcytosine-mediated epigenetic regulation leads to Purkinje cell vulnerability in ATM deficiency. Brain 138:3520–3536.
59. Kaminsky N, Bihari O, Kanner S, Barzilai A. 2016. Connecting malfunctioning glial cells and brain degenerative disorders. Genomics Proteomics Bioinformatics 14:155–165.
60. Kamsler A, Daily D, Hochman A, Stern N, Shiloh Y, Rotman G, Barzilai A. 2001. Increased oxidative stress in ataxia telangiectasia evidenced by alterations in redox state of brains from Atm-deficient mice. Cancer Res 61:1849–1854.
61. Kim GH, Kim JE, Rhie SJ, Yoon S. 2015. The role of oxidative stress in neurodegenerative diseases. Exp Neurobiol 24:325–340.
62. Kim J, Wong PK. 2009. Oxidative stress is linked to ERK1/2-p16 signaling-mediated growth defect in ATM-deficient astrocytes. J Biol Chem 284:14396–14404.
63. Kim J, Kundu M, Viollet B, Guan KL. 2011. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol 13:132–141.
64. Kim TS, Kawaguchi M, Suzuki M, Jung CG, Asai K, Shibamoto Y, Lavin MF, Khanna KK, Miura Y. 2010. The ZFHX3 (ATBF1) transcription factor induces PDGFRB, which activates ATM in the cytoplasm to protect cerebellar neurons from oxidative stress. Dis Model Mech 3:752–762.
65. Kozlov SV, Graham ME, Peng C, Chen P, Robinson PJ, Lavin MF. 2006. Involvement of novel autophosphorylation sites in ATM activation. EMBO J 25:3504–3514.
66. Kozlov SV, Waardenberg AJ, Engholm-Keller K, Arthur JW, Graham ME, Lavin M. 2016. Reactive Oxygen Species (ROS)-activated ATM-dependent phosphorylation of cytoplasmic substrates identified by large-scale phosphoproteomics screen. Mol Cell Proteomics 15:1032–1047.
67. Krohn NG, Brown NA, Colabardini AC, Reis T, Savoldi M, Dinamarco TM, Goldman MH, Goldman GH. 2014. The Aspergillus nidulans ATM Kinase (AtmA) Regulates Mitochondrial Function, Glucose Uptake and the Carbon Starvation Response. G3 (Bethesda) 4:49–62.
68. Kruiswijk F, Labuschagne CF, Vousden KH. 2015. p53 in survival, death and metabolic health: a lifeguard with a licence to kill. Nat Rev Mol Cell Biol 16:393–405.
69. Kuljis RO, Xu Y, Aguila MC, Baltimore D. 1997. Degeneration of neurons, synapses, and neuropil and glial activation in a murine Atm knockout model of ataxia-telangiectasia. Proc Natl Acad Sci U S A 94:12688–12693.
70. Kwong JQ, Beal MF, Manfredi G. 2006. The role of mitochondria in inherited neurodegenerative diseases. J Neurochem 97:1659–1675.
71. Lau WC, Li Y, Liu Z, Gao Y, Zhang Q, Huen MS. 2016. Structure of the human dimeric ATM kinase. Cell Cycle 15:1117–1124.
72. Lavin MF. 2013. The appropriateness of the mouse model for ataxia-telangiectasia: neurological defects but no neurodegeneration. DNA Repair 12:612–619.
73. Lavin MF, Kozlov S, Gatei M, Kijas AW. 2015. ATM-dependent phosphorylation of all three members of the MRN complex: from sensor to adaptor. Biomolecules 5:2877–28902.
74. Lavin MF, Yeo AJ, Kijas AW, Wolvetang E, Sly PD, Wainwright C, Sinclair K. 2016. Therapeutic targets and investigated treatments for Ataxia-Telangiectasia. Expert Opin Orphan Drugs 4:1263–1276.
75. Li J, Han YR, Plummer MR, Herrup K. 2009. Cytoplasmic ATM in neurons modulates synaptic function. Curr Biol 19:2091–2096.
76. Li J, Chen J, Ricupero CL, Hart RP, Schwartz MS, Kusnecov A, Herrup K. 2012. Nuclear accumulation of HDAC4 in ATM deficiency promotes neurodegeneration in ataxia telangiectasia. Nat Med 18:783–790.
77. Li Y, Xiong H, Yang DQ. 2012. Functional switching of ATM: sensor of DNA damage in proliferating cells and mediator of Akt survival signal in post-mitotic human neuron-like cells. Chin J Cancer 31:364–372.
78. Lim DS, Kirsch DG, Canman CE, Ahn JH, Ziv Y, Newman LS, Darnell RB, Shiloh Y, Kastan MB. 1998. ATM binds to β-adaptin in cytoplasmic vesicles. Proc Natl Acad Sci U S A 95:10146–10151.
79. Lismont C, Nordgren M, Van Veldhoven PP, Fransen M. 2015. Redox interplay between mitochondria and peroxisomes. Front Cell Dev Biol 3:35.
80. Liu N, Stoica G, Yan M, Scofield VL, Qiang W, Lynn WS, Wong PK. 2005. ATM deficiency induces oxidative stress and endoplasmic reticulum stress in astrocytes. Lab Invest 85:1471–1480.
81. López-Carballo G, Moreno L, Masiá S, Pérez P, Barettino D. 2002. Activation of the phosphatidylinositol 3-kinase/Akt signaling pathway by retinoic acid is required for neural differentiation of SH-SY5Y human neuroblastoma cells. J Biol Chem 277:25297–304.
82. Lyakhovich A, Graifer D, Stefanovie B, Krejci L. 2016. Mitochondrial dysfunction in DDR-related cancer predisposition syndromes. Biochim Biophys Acta 1865:184–189.
83. Macaulay VM, Salisbury AJ, Bohula EA, Playford MP, Smorodinsky NI, Shiloh Y. 2001. Downregulation of the type 1 insulin-like growth factor receptor in mouse melanoma cells is associated with enhanced radiosensitivity and impaired activation of Atm kinase. Oncogene 20:4029.
84. Maciejczyk M, Mikoluc B, Pietrucha B, Heropolitanska-Pliszka E, Pac M, Motkowski R, Car H. 2017. Oxidative stress, mitochondrial abnormalities and antioxidant defense in Ataxia-telangiectasia, Bloom syndrome and Nijmegen breakage syndrome. Redox 11:375–383.
85. Majdzadeh N, Wang L, Morrison BE, Bassel-Duby R, Olson EN, D'mello SR. 2008. HDAC4 inhibits cell-cycle progression and protects neurons from cell death. Dev Neurobiol 68:1076–92.
86. Matsuoka S, Ballif BA, Smogorzewska A, McDonald ER, Hurov KE, Luo J, Bakalarski CE, Zhao Z, Solimini N, Lerenthal Y, Shiloh Y, Gygi SP, Elledge SJ. 2007. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 316:1160–1166.
87. McInnes J. 2013. Insights on altered mitochondrial function and dynamics in the pathogenesis of neurodegeneration. Transl Neurodegener 2:12.
88. McKinnon PJ. 2012. ATM and the molecular pathogenesis of ataxia telangiectasia. Annu Rev Pathol 7:303–321.
89. McKinnon PJ. 2013. Maintaining genome stability in the nervous system. Nat Neurosci 16:1523–1529.
90. Menon S, Dibble CC, Talbott G, Hoxhaj G, Valvezan AJ, Takahashi H, Cantley LC, Manning BD. 2014. Spatial control of the TSC complex integrates insulin and nutrient regulation of mTORC1 at the lysosome. Cell 156:771–785.
91. Mercer JR, Yu E, Figg N, Cheng KK, Prime TA, Griffin JL, Masoodi M, Vidal-Puig A, Murphy MP, Bennett MR. 2012. The mitochondria-targeted antioxidant MitoQ decreases features of the metabolic syndrome in ATM+/–/ApoE–/–mice. Free Radic Biol Med 52:841–849.
92. Meredith MJ, Dodson ML. 1987. Impaired glutathione biosynthesis in cultured human ataxia-telangiectasia cells. Cancer Res 47:4576–4581.
93. Meshulam L, Galron R, Kanner S, De Pittà M, Bonifazi P, Goldin M, Frenkel D, Ben-Jacob E, Barzilai A. 2012. The role of the neuro-astro-vascular unit in the etiology of ataxia telangiectasia. Front Pharmacol 3:157.
94. Morita A, Tanimoto K, Murakami T, Morinaga T, Hosoi Y. 2014. Mitochondria are required for ATM activation by extranuclear oxidative stress in cultured human hepatoblastoma cell line Hep G2 cells. Biochem Biophys Res Commun 443:1286–1290.
95. Nayler S, Gatei M, Kozlov S, Gatti R, Mar JC, Wells CA, Lavin M, Wolvetang E. 2012. Induced pluripotent stem cells from ataxia-telangiectasia recapitulate the cellular phenotype. Stem Cells Transl Med 1:523–535.
96. Nissenkorn AN, Ben-Zeev BR. 2015. Ataxia telangiectasia. Handb Clin Neurol 132:199–214.
97. Nordgren M, Fransen M. 2014. Peroxisomal metabolism and oxidative stress. Biochimie 98:56–62.
98. Oka A, Takashima S. 1998. Expression of the ataxia-telangiectasia gene (ATM) product in human cerebellar neurons during development. Neurosci Lett 252:195–198.
99. Olcina MM, Foskolou IP, Anbalagan S, Senra JM, Pires IM, Jiang Y, Ryan AJ, Hammond EM. 2013. Replication stress and chromatin context link ATM activation to a role in DNA replication. Mol Cell 52:758–766.
100. Patel AY, McDonald TM, Spears LD, Ching JK, Fisher JS. 2011. Ataxia telangiectasia mutated influences cytochrome c oxidase activity. Biochem Biophys Res Commun 405:599–603.
101. Paull TT. 2015. Mechanisms of ATM activation. Annu Rev Biochem 84:711–738.
102. Peretz S, Jensen R, Baserga R, Glazer PM. 2001. ATM-dependent expression of the insulin-like growth factor-I receptor in a pathway regulating radiation response. Proc Natl Acad Sci U S A 98:1676–81.
103. Perlman SL, Boder Deceased E, Sedgewick RP, Gatti RA. 2012. Ataxia-telangiectasia. Handb Clin Neurol 103:307–332.
104. Petersen AJ, Rimkus SA, Wasserman DA. 2012. ATM kinase inhibition in glial cells activates the innate immune response and causes neurodegeneration in Drosophila. Proc Natl Acad Sci U S A 109:E656–E664.
105. Pizzamiglio L, Focchi E, Murru L, Tamborini M, Passafaro M, Menna E, Matteoli M, Antonucci F. 2016. New Role of ATM in Controlling GABAergic Tone During Development. Cereb Cortex 26:3879–3888.
106. Quek H, Luff J, Cheung K, Kozlov S, Gatei M, Lee CS, Bellingham MC, Noakes PG, Lim YC, Barnett NL, Dingwall S, Wolvetang E, Mashimo T, Roberts TL, Lavin MF. 2017a. A rat model of ataxia-telangiectasia: evidence for a neurodegenerative phenotype Hum Mol Genet 26:109–123.
107. Quek H, Luff J, Cheung K, Kozlov S, Gatei M, Lee CS, Bellingham MC, Noakes PG, Lim YC, Barnett NL, Dingwall S, Wolvetang E, Mashimo T, Roberts TL, Lavin MF. 2017b. Rats with a missense mutation in Atm display neuroinflammation and neurodegeneration subsequent to accumulation of cytosolic DNA following unrepaired DNA damage. J Leukoc Biol 101:927–947.
108. Qi Y, Qiu Q, Gu X, Tian Y, Zhang Y. 2016. ATM mediates spermidine-induced mitophagy via PINK1 and Parkin regulation in human fibroblasts. Sci Rep 6:24700.
109. Quick KL, Dugan LL. 2001. Superoxide stress identifies neurons at risk in a model of ataxia-telangiectasia. Ann Neurol 49:627–635.
110. Raz-Prag D, Galron R, Segev-Amzaleg N, Solomon AS, Shiloh Y, Barzilai A, Frenkel D. 2011. A role for vascular deficiency in retinal pathology in a mouse model of ataxia-telangiectasia. Am J Pathol 179:1533–1541.
111. Reichenbach J, Schubert R, Schwan C, Müller K, Böhles HJ, Zielen S. 1999. Anti-oxidative capacity in patients with ataxia telangiectasia. Clin Exp Immunol 117:535–539.
112. Reichenbach J, Schubert R, Schindler D, Müller K, Böhles H, Zielen S. 2002. Elevated oxidative stress in patients with ataxia telangiectasia. Antioxid Redox Signal 4:465–469.
113. Reliene R, Fischer E, Schiestl RH. 2004. Effect of N-acetyl cysteine on oxidative DNA damage and the frequency of DNA deletions in atm-deficient mice. Cancer Res 64:5148–5153.
114. Reliene R, Schiestl RH. 2008. Experimental antioxidant therapy in ataxia telangiectasia. Clin Med Oncol 2:431–436.
115. Resseguie EA, Staversky RJ, Brookes PS, O'Reilly MA. 2015. Hyperoxia activates ATM independent from mitochondrial ROS and dysfunction. Redox Biol 5:176–185.
116. Rhodes N, D'Souza T, Foster CD, Ziv Y, Kirsch DG, Shiloh Y, Kastan MB, Reinhart PH, Gilmer TM. 1998. Defective potassium currents in ataxia telangiectasia fibroblasts. Genes Dev 12:3686–3692.
117. Rothblum-Oviatt C, Wright J, Lefton-Greif MA, McGrath-Morrow SA, Crawford TO, Lederman HM. 2016. Ataxia telangiectasia: a review. Orphanet J Rare Dis 11:159.
118. Sarbassov DD, Ali SM, Sabatini DM. 2005. Growing roles for the mTOR pathway. Curr Opin Cell Biol 17:596–603.
119. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle DA, Smith S, Uziel T, Sfez S, Ashkenazi M, Pecker I, Frydman M, Harnik R, Patanjali SR, Simmons A, Clines GA, Sartiel A, Gatti RA, Chessa L, Sanal O, Lavin MF, Jaspers NG, Taylor AM, Arlett CF, Miki T, Weissman SM, Lovett M, Collins FS, Shiloh Y. 1995. A single ataxia telangiectasia gene with a product similar to Pl-3 kinase. Science 268:1749–1753.
120. Sawicka M, Wanrooij PH, Darbari VC, Tannous E, Hailemariam S, Bose D, Makarova AV, Burgers PM, Zhang X. 2016. The dimeric architecture of checkpoint kinases Mec1ATR and Tel1ATM reveal a common structural organization. J Biol Chem 291:13436–13447.
121. Schneider JG, Finck BN, Ren J, Standley KN, Takagi M, Maclean KH, Bernal-Mizrachi C, Muslin AJ, Kastan MB, Semenkovich CF. 2006. ATM-dependent suppression of stress signaling reduces vascular disease in metabolic syndrome. Cell Metab 4:377–389.
122. Schrader M, Fahimi HD. 2006. Peroxisomes and oxidative stress. Biochim Biophys Acta 1763:1755–1766.
123. Schrader M, Costello J, Godinho LF, Islinger M. 2015. Peroxisome-mitochondria interplay and disease. J Inherit Metab Dis 38:681–702.
124. Sedgwick RP, Boder E. 1991. Hereditary neuropathies and spinocerebellar atrophies. Handb Clin Neurol 16:347–423.
125. Shackelford RE, Manuszak RP, Johnson CD, Hellrung DJ, Link CJ, Wang S. 2004. Iron chelators increase the resistance of Ataxia telangeictasia cells to oxidative stress. DNA Repair 3:1263–1272.
126. Shaikh AG, Crawford TO, Zee DS, Jinnah HA. 2009. Movement disorders in ataxia-telangiectasia. Mov Disord 24:S21–22.
127. Shaikh AG, Zee DS, Mandir AS, Lederman HM, Crawford TO. 2013. Disorders of upper limb movements in ataxia-telangiectasia. PLoS One 8:e67042.
128. Sharma NK, Lebedeva M, Thomas T, Kovalenko OA, Stumpf JD, Shadel GS, Santos JH. 2014. Intrinsic mitochondrial DNA repair defects in Ataxia Telangiectasia. DNA Repair 13:22–31.
129. Shen X, Chen J, Li J, Kofler J, Herrup K. 2016. Neurons in Vulnerable Regions of the Alzheimer's Disease Brain Display Reduced ATM Signaling. eNeuro 3:ENEURO-0124-15.2016
130. Shiloh Y, Lederman HM. 2017. Ataxia-telangiectasia (AT): An emerging dimension of premature ageing. Ageing Res Rev 33:76–88.
131. Shiloh Y, Ziv Y. 2013. The ATM protein kinase: regulating the cellular response to genotoxic stress, and more. Nat Rev Mol Cell Biol 14:197–210.
132. Siddoway B, Hou H, Yang H, Petralia R, Xia H. 2014. Synaptic activity bidirectionally regulates a novel sequence-specific S-Q phosphoproteome in neurons. J Neurochem 128:841–851.
133. Spring K, Cross S, Li C, Watters D, Ben-Senior L, Waring P, Ahangari F, Lu SL, Chen P, Misko I, Paterson C, Kay G, Smorodinsky NI, Shiloh Y, Lavin MF. 2001. Atm knock-in mice harboring an in-frame deletion corresponding to the human ATM 7636del9 common mutation exhibit a variant phenotype. Cancer Res 11:4561–4568.
134. Stern N, Hochman A, Zemach N, Weizman N, Hammel I, Shiloh Y, Rotman G, Barzilai A. 2002. Accumulation of DNA damage and reduced levels of nicotine adenine dinucleotide in the brains of Atm-deficient mice. J Biol Chem 277:602–608.
135. Stewart R, Kozlov S, Matigian N, Wali G, Gatei M, Sutharsan R, Bellette B, Kijas AW, Cochrane J, Coulthard M, Perry C, Sinclair K, Mackay-Sim A, Lavin MF. 2013. A patient-derived olfactory stem cell disease model for ataxia-telangiectasia. Hum Mol Genet 22:2495–2509.
136. Su Y, Swift M. 2000. Mortality rates among carriers of ataxia-telangiectasia mutant alleles. Ann Intern Med 133:770–778.
137. Subramani S. 2015. A mammalian pexophagy target. Nat Cell Biol 17:1371–1373
138. Sullivan KD, Palaniappan VV, Espinosa JM. 2015. ATM regulates cell fate choice upon p53 activation by modulating mitochondrial turnover and ROS levels. Cell Cycle 14:56–63.
139. Taylor A, Shang F, Nowell T, Galanty Y, Shiloh Y. 2002. Ubiquitination capabilities in response to neocarzinostatin and H2O2 stress in cell lines from patients with ataxia-telangiectasia. Oncogene 21:4363–4373.
140. Taylor AM, Lam Z, Last JI, Byrd PJ. 2015. Ataxia telangiectasia: more variation at clinical and cellular levels. Clin Genet 87:199–208.
141. Teive HA, Moro A, Moscovich M, Arruda WO, Munhoz RP, Raskin S, Ashizawa T. 2015. Ataxia-telangiectasia—A historical review and a proposal for a new designation: ATM syndrome. J Neurol Sci 355:3–6.
142. Tian B, Yang Q, Mao Z. 2009. Phosphorylation of ATM by Cdk5 mediates DNA damage signalling and regulates neuronal death. Nat Cell Biol 11:211–218.
143. Till A, Lakhani R, Burnett SF, Subramani S. 2012. Pexophagy: the selective degradation of peroxisomes Int J Cell Biol 2012:512721.
144. Trempe JF, Fon EA. 2013. Structure and function of Parkin, PINK1, and DJ-1, the three musketeers of neuroprotection. Front Neurol 4:38.
145. Tripathi DN, Chowdhury R, Trudel LJ, Tee AR, Slack RS, Walker CL, Wogan GN. 2013. Reactive nitrogen species regulate autophagy through ATM-AMPK-TSC2–mediated suppression of mTORC1. Proc Natl Acad Sci U S A 110:E2950–E2957.
146. Tripathi DN, Walker CL. 2016. The peroxisome as a cell signalling organelle. Curr Opin Cell Biol 39:109–112.
147. Valentin-Vega YA, MacLean KH, Tait-Mulder J, Milasta S, Steeves M, Dorsey FC, Cleveland JL, Green DR, Kastan MB. 2012. Mitochondrial dysfunction in ataxia-telangiectasia. Blood 119:1490–1500.
148. Vail G, Cheng A, Han YR, Zhao T, Du S, Loy KH, Herrup K, Plummer MR. 2016. ATM protein is located on presynaptic vesicles and its. J Neurophysiol 116:201–209.
149. van Vliet AR, Verfaillie T, Agostinis P. 2014. New functions of mitochondria associated membranes in cellular signaling. Biochim Biophys Acta 1843:2253–2262.
150. Verhagen MM, Martin JJ, van Deuren M, Ceuterick-de Groote C, Weemaes CM, Kremer BH, Taylor MA, Willemsen MA, Lammens M. 2012. Neuropathology in classical and variant ataxia-telangiectasia. Neuropathology 32:234–244.
151. Viniegra JG, Martínez N, Modirassari P, Losa JH, Cobo CP, Lobo VJ, Avceves-Luquero CI, Alavrez-Vallina L, Ramón y Cajal S, Rojas JM, Sánchez-Prieto R. 2004. Full activation of PKB/Akt in response to insulin or ionizing radiation is mediated through ATM. J Biol Chem 280:4029–4036.
152. Vinters HV, Gatti RA, Rakic P. 1984. Sequence of cellular events in cerebellar ontogeny relevant to expression of neuronal abnormalities in ataxia-telangiectasia. Kroc Found Ser 19:233–255.
153. Volkow ND, Tomasi D, Wang GJ, Studentsova Y, Margus B, Crawford TO. 2014. Brain glucose metabolism in adults with ataxia-telangiectasia and their asymptomatic relatives. Brain 137:1753–1761.
154. Wang DB, Kinoshita C, Kinoshita Y, Morrison RS. 2014. p53 and mitochondrial function in neurons. Biochim Biophys Acta 1842:1186–1197.
155. Wang X, Chu H, Lv M, Zhang Z, Qiu S, Liu H, Shen X, Wang W, Cai G. 2016. Structure of the intact ATM/Tel1 kinase. Nat Commun 7:11655.
156. Watters D, Kedar P, Spring K, Bjorkman J, Chen P, Gatei M, Birrell G, Garrone B, Srinivasa P, Crane DI, Lavin MF. 1999. Localization of a portion of extranuclear ATM to peroxisomes. J Biol Chem 274:34277–34282.
157. Wei FY, Tomizawa K, Ohshima T, Asada A, Saito T, Nguyen C, Bibb JA, Ishiguro K, Kulkarni AB, Pant HC, Mikoshiba K, Matsui H, Hisanaga S. 2005. Control of cyclin-dependent kinase 5 (Cdk5) activity by glutamatergic regulation of p35 stability. J Neurochem 93:502–512.
158. Werner H, LeRoith D. 2014. Insulin and insulin-like growth factor receptors in the brain: physiological and pathological aspects. Eur Neuropsychopharmacol 24:1947–1953.
159. Weyemi U, Redon CE, Aziz T, Choudhuri R, Maeda D, Parekh PR, Bonner MY, Arbiser JL, Bonner WM. 2015. NADPH oxidase 4 is a critical mediator in Ataxia telangiectasia disease. Proc Natl Acad Sci U S A 112:2121–2126.
160. Xu Y, Baltimore D. 1996. Dual roles of ATM in the cellular response to radiation and in cell growth control. Genes Dev 10:2401–2410.
161. Yang DQ, Kastan MB. 2000. Participation of ATM in insulin signalling through phosphorylation of eIF-4E-binding protein 1. Nat Cell Biol 2:893–898.
162. Yang Y, Herrup K. 2005. Loss of neuronal cell cycle control in ataxia-telangiectasia: a unified disease mechanism. J Neurosci 25:2522–2529.
163. Yang Y, Hui CW, Li J, Herrup K. 2014. The interaction of the atm genotype with inflammation and oxidative stress. PLoS One 9:e85863.
164. Yamamoto K, Wang Y, Jiang W, Liu X, Dubois, RL, Lin CS, Ludwig T, Bakkenist CJ, Zha S. 2012. Kinase-dead ATM protein causes genomic instability and early embryonic lethality in mice. J Cell Biol 198:305–313.
165. Zhang J, Kim J, Alexander A, Cai S, Tripathi DN, Dere R, Tee AR, Tait-Mulder J, Di Nardo A, Han JM, Kwiatkowski E, Dunlop EA, Dodd KM, Folkerth RD, Faust PL, Kastan MB, Sahin M, Walker CL. 2013. A tuberous sclerosis complex signalling node at the peroxisome regulates mTORC1 and autophagy in response to ROS. Nat Cell Biol 15:1186–1196.
166. Zhang J, Tripathi DN, Jing J, Alexander A, Kim J, Powell RT, Dere R, Tait-Mulder J, Lee JH, Paull TT, Pandita RK, Kastan MB, Walker CL. 2015. ATM functions at the peroxisome to induce pexophagy in response to ROS. Nat Cell Biol 17:1259–1269.